1-20 of 25
Adrien Chauchet
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy of CAR T-cell therapy is not impaired by previous bispecific antibody treatment in large B-cell lymphoma

Clinical Trials & Observations
Gilles Crochet, Gloria Iacoboni, Audrey Couturier, Emmanuel Bachy, Josu Iraola-Truchuelo, Thomas Gastinne, Guillaume Cartron, Tom Fradon, Bastien Lesne, Mi Kwon, Romain Gounot, Nuria Martínez-Cibrian, Cristina Castilla-Llorente, Pau Abrisqueta, Manuel Guerreiro, Clémentine Sarkozy, Jose María Aspa-Cilleruelo, Vincent Camus, Stéphanie Guidez, Adrien Chauchet, Eric Deconinck, Krimo Bouabdallah, Francesc Bosch, Pere Barba, Franck Morschhauser, Roch Houot
Journal: Blood
Blood (2024) 144 (3): 334–338.
https://doi.org/10.1182/blood.2024024526
Published: 2024
Includes: Supplemental data
Journal Articles

High efficacy of CD19 CAR T cells in patients with transformed Waldenström macroglobulinemia

Clinical Trials & Observations
Eric Durot, Damien Roos-Weil, Adrien Chauchet, Justine Decroocq, Roberta Di Blasi, Thomas Gastinne, Hedi Bensaber, Morgane Cheminant, Caroline Jacquet, Stéphanie Guidez, François-Xavier Gros, Emmanuel Bachy, Arthur Coste, Pascale Cony-Makhoul, Steven P. Treon, Alain Delmer, Ran Reshef, Steven Le Gouill, Jorge J. Castillo, Roch Houot
Journal: Blood
Blood (2024) 143 (26): 2804–2807.
https://doi.org/10.1182/blood.2024024452
Published: 2024
Includes: Supplemental data
Journal Articles

Efficacy of Chimeric Antigen Receptor T-Cell Therapy Is Not Impaired By Previous Bispecific Antibody Treatment in Patients with Large B-Cell Lymphoma

Gloria Iacoboni, Gilles Crochet, Audrey Couturier, Emmanuel Bachy, Josu Iraola, Thomas Gastinne, Charles Herbaux, Tom Fradon, Mi Kwon, Romain Gounot, Nuria Martinez-Cibrian, Cristina Castilla-Llorente, Manuel Guerreiro, Clementine Sarkozy, Jose Aspa-Cilleruelo, Vincent Camus, Stephanie Guidez, Adrien Chauchet, Eric Deconinck, Krimo Bouabdallah, Pere Barba, Roch Houot, Franck Morschhauser
Journal: Blood
Blood (2023) 142 (Supplement 1): 228.
https://doi.org/10.1182/blood-2023-185035
Published: 2023
Journal Articles

CD19-Targeting CAR T-Cell Therapy in Transformed Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma: A Descar-T and US Collaborative Study

Eric Durot, Damien Roos-Weil, Adrien Chauchet, Justine Decroocq, Roberta Di Blasi, Thomas Gastinne, Hedi Bensader, Morgane Cheminant, Caroline Jacquet, Stephanie Guidez, François-Xavier Gros, Emmanuel Bachy, Pascale Cony-Makhoul, Steven P Treon, Alain Jacques Delmer, Ran Reshef, Steven Le Gouill, Jorge J. Castillo, Roch Houot
Journal: Blood
Blood (2023) 142 (Supplement 1): 616.
https://doi.org/10.1182/blood-2023-173988
Published: 2023
Journal Articles

Verlen, “Very Elderly Rituximab Associated to Lenalidomide - Tafasitamab Combination in Frontline DLBCL Patients”, a Phase II Open-Label Study Evaluating Efficacy of Lenalinomide and Tafasitamab Combination Associated to Rituximab in Frontline Diffuse Large B-Cell Lymphoma Patients of 80 y/o or Older from the Lysa Group

Benoit Tessoulin, Julien Depaus, Pierre Feugier, Ludovic Fouillet, Julie Abraham, Sandy Amorin, Fabrice Jardin, Franck Morschhauser, Catherine Thieblemont, François-Xavier Gros, Bertrand Joly, Hacene Zerazhi, Sophie Bernard, Adrien Chauchet, Stéphane Vigouroux, Christophe Bonnet, Sarah Bailly, Steven Le Gouill
Journal: Blood
Blood (2023) 142 (Supplement 1): 3094.
https://doi.org/10.1182/blood-2023-173265
Published: 2023
Journal Articles

CAR T-Cell Therapy Remain Effective in Patients with Relapse/Refractory B-Cell Non-Hodgkin Lymphoma after Bispecific Antibodies Exposure: Results of a Lysa Study Based on the Descar-T Registry

Gilles Crochet, Couturier Audrey, Emmanuel Bachy, Thomas Gastinne, Guillaume Cartron, Tom Fradon, Romain Gounot, Cristina Castilla-LLorente, Clementine Sarkozy, Vincent Camus, Stéphanie Guidez, Adrien Chauchet, Eric Deconinck, Krimo Bouabdallah, Franck Morschhauser, Roch Houot
Journal: Blood
Blood (2022) 140 (Supplement 1): 4639–4641.
https://doi.org/10.1182/blood-2022-162594
Published: 2022
Journal Articles

Addition of Brentuximab Vedotin to Gemcitabine in Relapsed or Refractory T-Cell Lymphoma: Final Analysis of a Lysa Multicenter, Phase II Study. "the TOTAL Trial"

Olivier Tournilhac, Solene Lecolant, Maya Hacini, Krimo Bouabdallah, Sebastien Bailly, Kamel Laribi, Thibaut Belmondo, Marie Maerevoet, Loic Ysebaert, Stéphanie Guidez, Steven Le Gouill, Christophe Bonnet, Marc Andre, Jehan Dupuis, Catherine Thieblemont, Emmanuel Bachy, Nicolas Daguindau, Franck Morschhauser, Sabine Tricot, Pierre Feugier, Anne Banos, Thierry Lamy, Adrien Chauchet, Emmanuel Gyan, Guillaume Cartron, Hassan Farhat, Vincent Camus, Bernard Drenou, Hacene Zerazhi, David Sibon, Emmanuelle Nicolas-Virelizier, Caroline Delette, Sylvia Snauwaert, Nicole Straetmans, Richard Delarue, Marie Parrens, Samuel Griolet, Philippe Gaulard, Marie-Helene Delfau-Larue, Laurence De Leval, Gandhi Laurent Damaj
Journal: Blood
Blood (2022) 140 (Supplement 1): 2302–2305.
https://doi.org/10.1182/blood-2022-165217
Published: 2022
Journal Articles

The POLARIX Study: Polatuzumab Vedotin with Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (pola-R-CHP) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) Therapy in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma

Hervé Tilly, Franck Morschhauser, Laurie H. Sehn, Jonathan W. Friedberg, Marek Trněný, Jeff P. Sharman, Charles Herbaux, John M. Burke, Matthew Matasar, Shinya Rai, Koji Izutsu, Neha Mehta-Shah, Lucie Oberic, Adrien Chauchet, Wojciech Jurczak, Yuqin Song, Richard Greil, Larysa Mykhalska, Juan Miguel Bergua Burgués, Matthew C. Cheung, Antonio Pinto, Ho-Jin Shin, Greg Hapgood, Eduardo Munhoz, Pau Abrisqueta Costa, Jyh-Pyng Gau, Jamie Hirata, Yanwen Jiang, Mark Yan, Calvin Lee, Christopher R. Flowers, Gilles Salles
Journal: Blood
Blood (2021) 138 (Supplement 2): LBA-1.
https://doi.org/10.1182/blood-2021-154729
Published: 2021
Journal Articles

The Eatl-001 Trial: Results of a Phase 2 Study of Brentuximab Vedotin and CHP Followed By Consolidation with High-Dose Therapy - Autologous Stem-Cell Transplantation (HDT-ASCT) in the Frontline Treatment of Patients with Enteropathy-Associated T-Cell Lymphoma

David Sibon, Sherine Khater, Julie Bruneau, Chantal Brouzes, Ludovic Lhermitte, Thierry Jo Molina, Guillaume Cartron, Veronique Morel, Georgia Malamut, Adrien Chauchet, Franck Morschhauser, Baptiste Perard, Jean-Michel Boulet, Anne-Cécile Gauchy, Nadine Cerf-Bensussan, Elizabeth A. Macintyre, Vahid Asnafi, Christophe Cellier, Olivier Hermine
Journal: Blood
Blood (2021) 138 (Supplement 1): 136.
https://doi.org/10.1182/blood-2021-153709
Published: 2021
Journal Articles

Outcomes of Allogeneic Hematopoietic Cell Transplantation (allo-HCT) for Adults with Primary Mediastinal B Cells Lymphoma (PMBCL): A Retrospective Study on Behalf of the Société Francophone De Greffe De Moelle Et De Thérapie Cellulaire (SFGM-TC) and the Lymphoma Study Association (LYSA) Group

Baptiste Le Calvez, Benoit Tessoulin, Loic Renaud, Carmen Botella-Garcia, Micha Srour, Steven Le Gouill, Gaelle Guillerm, Rémy Gressin, Stephanie Nguyen, Sabine Furst, Adrien Chauchet, David Sibon, Philippe Lewalle, Xavier Poire, Natacha Maillard, Alban Villate, Michael Loschi, Mathilde Hunault, Yves Beguin, Remy Dulery, Jean Jacques Tudesq, Vincent Camus, Patrice Chevallier, Amandine Le Bourgeois, Amandine Fayard
Journal: Blood
Blood (2021) 138 (Supplement 1): 1826.
https://doi.org/10.1182/blood-2021-146857
Published: 2021
Journal Articles

Salvage Therapy with Brentuximab-Vedotin and Bendamustine for Patients with Relapsed/Refractory T Cell Lymphoma. a Multicenter and Retrospective Study

Krimo Bouabdallah, Raphaëlle Aubrais, Loïc Chartier, Charles Herbaux, Anne Banos, Pauline Brice, Marlene Ochmann, David Sibon, Jean Marc Schiano De Colella, Thomas Cluzeau, Kamel Laribi, Ronan Le Calloch, Mathieu Bellal, Nicolas Daguindau, Sandy Amorim, Kossi Agbetiafa, Adrien Chauchet, Marwa Hammami, Eric Durot, Christophe Bonnet, Margot Robles, Ludovic Fouillet, Fontanet Bijou, Olivier Tournilhac, Philippe Gaulard, Marie Parrens, Noel-Jean Milpied, Gandhi Laurent Damaj
Journal: Blood
Blood (2021) 138 (Supplement 1): 620.
https://doi.org/10.1182/blood-2021-150953
Published: 2021
Journal Articles

Radiotherapy (WBRT) or Autologous Stem-Cell Transplantation (ASCT) for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Long-Term Results of the Intergroup Anocef-Goelams Randomized Phase II Precis Study

Caroline Houillier, Luc Taillandier, Roch Houot, Olivier Chinot, Cecile Molucon-Chabrot, Anna Schmitt, Rémy Gressin, Choquet Sylvain, Gandhi Laurent Damaj, Julie Abraham, Vincent Delwail, Emmanuel Gyan, Sylvain Dureau, Laurence Sanhes, Jérôme Cornillon, Reda Garidi, Alain Delmer, Marie-laure Tanguy, Ahmad Kanj AL Jijakli, Pierre Morel, Marie-Pierre Moles, Adrien Chauchet, Thomas Gastinne, Loïc Feuvret, Nathalie Cassoux, Valerie Touitou, Damien Ricard, Frédéric Peyrade, Mouna Laadhari, Anne-Sophie Plissonnier, Khe Hoang-Xuan, Carole Soussain
Journal: Blood
Blood (2021) 138 (Supplement 1): 658.
https://doi.org/10.1182/blood-2021-146389
Published: 2021
Journal Articles

PVAG Regimen (Prednisone, Vinblastine, Doxorubicin, Gemcitabine) Used in Real-Life Setting in First Line Therapy for Elderly Classical Hodgkin Lymphoma Patients: A Retrospective Study of Lysa Centers

Guillaume Aussedat, Maryam Idlhaj, Amandine Durand, Xavier Roussel, Pauline Brice, MD, Gilles Salles, MDPhD, Benedicte Deau Fischer, Adrien Chauchet, MD, Cedric Rossi, MD PhD, Herve Ghesquieres, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11.
https://doi.org/10.1182/blood-2020-138706
Published: 2020
Journal Articles

Addition of Brentuximab Vedotin to Gemcitabine in Relapsed or Refractory T-Cell Lymphoma: Results of a Lysa Multicenter, Phase II Study. "the TOTAL Trial"

Olivier Tournilhac, MD PhD, Maya Hacini, MD, Kamal Bouabdallah, MD, Kamel Laribi, MD, Marie Maerevoet, MD, Loic Ysebaert, MD PhD, Stephanie Guidez, Steven Le Gouill, MD PhD, Marc André, MD, Jehan Dupuis, MD, Catherine Thieblemont, MD PhD, Emmanuel Bachy, MD PhD, Nicolas Daguindau, MD, Franck Morschhauser, MD PhD, Sabine Tricot, MD, Pierre Feugier, MD PhD, Anne Banos, MD, Thierry Lamy De La Chapelle, MD PhD, Adrien Chauchet, MD, Emmanuel Gyan, MD PhD, Guillaume Cartron, MD PhD, Hassan Farhat, MD, Vincent Camus, Bernard Drenou, MD PhD, Hacene Zerazhi, MD, David Sibon, MD PhD, Emmanuelle Nicolas-Virelizier, MD, Caroline Delette, MD, Sylvia Snauwaert, MD, Nicole Straetmans, MD, Richard Delarue, MD, Marie Parrens, MD, Céline Bossard, MD, Laurence De Leval, MD, Philippe Gaulard, MD PhD, Gandhi Laurent Damaj, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 15–16.
https://doi.org/10.1182/blood-2020-139224
Published: 2020
Journal Articles

R-CHOP14 As a Standard of Care in Primary Mediastinal B Cell Lymphoma: A 10-YEARS Experience of Lysa Centers

Vincent Camus, Alina Berriolo-Riedinger, Justine Lequesne, David Tonnelet, MD, Pierre Decazes, Cédric Rossi, MD PhD, Pierre Sesques, MD, Corinne Haioun, MD PhD, Eric Durot, MD, Alexandre Willaume, Martin Gauthier, Marie-Pierre Moles, MD, Chloe Antier, Julien Lazarovici, MD, Helene Monjanel, Sophie Bernard, Magalie Tardy, Caroline Besson, MDPhD, Laure Lebras, MD, Choquet Sylvain, Katell Le Du, MD, Christophe Bonnet, MD, Sarah Bailly, MD, Damaj Gandhi Laurent, MD PhD, Kamel Laribi, MD, Herve Maisonneuve, MD, Roch Houot, MDPhD, Adrien Chauchet, MD, Fabrice Jardin, MD PhD, Stephanie Becker, MD, Herve Tilly, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 20–21.
https://doi.org/10.1182/blood-2020-136600
Published: 2020
Journal Articles

Amahrelis : Adcetris Maintenance after Autologous Stem Cell Transplantation in Hodgkin Lymphoma : A Real Life Study from Sfgmtc and Lysa Groups

Amira Marouf, Anne Ségolène Cottereau, MD, Guillemette Fouquet, MD, Salim Kanoun, MD, Patricia Franchi, MD, Romain Ricci, Michel Meignan, MD, David Sibon, MD PhD, Thomas Gastinne, MD, Cecile Borel, MD, Mohammad Hammoud, MD, Guillaume Sicard, MD, Romane Gille, Doriane Cavalieri, MD, Aspasia Stamatoulas Bastard, MD, Lauriane Clement-Filliatre, MD, Julien Lazarovici, MD, Adrien Chauchet, MD, Luc Mathieu Fornecker, MD PhD, Sandy Amorin, MD, Mathieu Roquet, Nicole Raus, Data Manager, Rene-Olivier Casasnovas, MD, Guillaume Cartron, MD PhD, Hervé Ghesquieres, MD PhD, Pauline Brice, MD, Olivier Hermine, Didier Bouscary, MDPhD, Marie Thérèse Rubio, MD PhD, Jerome Tamburini, MD PhD, Benedicte Deau Fischer
Journal: Blood
Blood (2020) 136 (Supplement 1): 20–21.
https://doi.org/10.1182/blood-2020-138666
Published: 2020
Journal Articles

Somatic Mutation Profile Analyzed By Next-Generation Sequencing in Relapsed/Refractory Follicular Lymphoma Treated with Idelalisib

Philippine Robert, Cédric Rossi, MD PhD, Romain Aucagne, PhD, Caroline Chapusot, Selim Ramla, MD, Robin Noel, MD, Reda Bouabdallah, Morgan Avenin, MD, Luc Xerri, MD PhD, Elise Toussaint, MD, Marie-Pierre Chenard, MD PhD, Luc Mathieu Fornecker, MD PhD, Adrien Chauchet, MD, Isabelle Bedgedjian, MD, Anne Quinquenel, MD, Saviz Nasri, Aude Marchal, MD PhD, Alain Jacques Delmer, MD PhD, Juliette Bouteloup, MD, Jean-Noel Bastie, MD PhD, Laurent Martin, MD PhD, Mary Callanan, PhD, Olivier Casasnovas, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1503.
https://doi.org/10.1182/blood-2019-126459
Published: 2019
Journal Articles

Superiority of Allogenic Stem Cell Transplantation after Anti-PD1 Therapy over Anti-PD1 Monotherapy Alone in Relapse/Refractory Hodgkin Lymphoma: Real World Evidence from the French Early Access Program

Guillaume Manson, MD, Jean-Baptiste Mear, MD, Charles Herbaux, MD, Jean Marc Schiano de Collela, MD, Rene-Olivier Casasnovas, MD, Aspasia Stamatoullas, MD, Bénédicte Deau-Fisher, MD, Anna Schmitt, Georges Garnier, MD, Lysiane Molina, MD, Krimo Bouabdallah, MD, Marie-Pierre Moles, Herv Ghesquieres, Adrian Tempescul, MD, Remy Dulery, MD, Emmanuelle Nicolas-Virelizier, MD, Alain Jacques Delmer, MD, Cecile Borel, MD, Adrien Chauchet, MD, Laurent Dercle, MD, Pauline Brice, MD, Roch Houot, Pr, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1638.
https://doi.org/10.1182/blood-2018-99-110960
Published: 2018
Journal Articles

Efficacy of Chemotherapy or Chemo-Anti-PD-1 Combination after Unsatisfactory Response of Anti-PD-1 Therapy for Relapsed and Refractory Hodgkin Lymphoma: A Retrospective Series from Lysa Centers

Cédric Rossi, MD, Julia Gilhodes, Marie Maerevoet, MD, Charles Herbaux, Pauline Brice, MD, Sylvain Garciaz, Cecile Borel, MD, Loic Ysebaert, MD PhD, Lucie Oberic, MD, Julien Lazarovici, MD, Bénédicte Deau-Fisher, MD, Jehan Dupuis, MD, Adrien Chauchet, Julie Abraham, MD, Fontanet Bijou, Aspasia Stamatoullas-Bastard, Jean Valère Malfuson, Camille Golfier, Camille Laurent, MDPhD, Salim Kanoun, MD, Thomas Filleron, PhD, Rene-Olivier Casasnovas, MD, Hervé Ghesquières, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 652.
https://doi.org/10.1182/blood.V130.Suppl_1.652.652
Published: 2017
Journal Articles

Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma

Clinical Trials & Observations
Charles Herbaux, Jordan Gauthier, Pauline Brice, Elodie Drumez, Loic Ysebaert, Hélène Doyen, Luc Fornecker, Krimo Bouabdallah, Guillaume Manson, Hervé Ghesquières, Reza Tabrizi, Eric Hermet, Julien Lazarovici, Anne Thiebaut-Bertrand, Adrien Chauchet, Hélène Demarquette, Eileen Boyle, Roch Houot, Ibrahim Yakoub-Agha, Franck Morschhauser
Journal: Blood
Blood (2017) 129 (18): 2471–2478.
https://doi.org/10.1182/blood-2016-11-749556
Published: 2017